Our team has a broad expertise in running all kinds of outcomes research studies throughout the entire product life cycle. A specific area of expertise includes prospective, retrospective and cross-sectional observational studies.
Such studies allow you to examine patterns of care, outcomes, and costs among identified populations treated in a "real-world" setting as determined by primary research (prospective studies) or as reflected by IMS databases or using secondary research (retrospective studies).
They address questions like:
-
How do patterns of physician treatment or prescribing affect clinical and economic outcomes?
-
How do patient behaviors affect outcomes?
-
What are the costs associated with treating a particular disease with a particular drug or intervention?
-
Is the observed situation in the real life comparable to the experimental or simulated situation?
The key target audiences include decision makers in Health Economics and Outcomes Research, Epidemiology, Drug Safety, Medical and Public Affairs.
IMS Health Economics and Outcomes Research has skills and expertise in the design and analysis of such studies and has partnered with CRO's for the set-up and implementation.